Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.

about

Sleep Disorders, Restless Legs Syndrome, and Uremic Pruritus: Diagnosis and Treatment of Common Symptoms in Dialysis Patients.

P2860

Q30244951-CD9A899E-7EA0-41D2-B928-9479D814E84E

P2860

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.

Item

http://www.wikidata.org/entity/Q38528368

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Augmentation of restless leg s ...... g-term dopaminergic treatment.

@en

type

Item

label

Augmentation of restless leg s ...... g-term dopaminergic treatment.

@en

prefLabel

Augmentation of restless leg s ...... g-term dopaminergic treatment.

@en

P1476

Augmentation of restless leg s ...... g-term dopaminergic treatment.

@en

P2093

Arturo Benitez

http://www.w3.org/2001/XMLSchema#string

Diego Garcia-Borreguero

http://www.w3.org/2001/XMLSchema#string

Ralf Kohnen

http://www.w3.org/2001/XMLSchema#string

P2860

The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group

A 52-week open-label study of the long-term safety of ropinirole in patients with restless legs syndrome

Dopamine D2 receptor expression is altered by changes in cellular iron levels in PC12 cells and rat brain tissue

Genome-wide association study identifies novel restless legs syndrome susceptibility loci on 2p14 and 16q12.1

Decreased transferrin receptor expression by neuromelanin cells in restless legs syndrome.

T2 relaxometry and fMRI of the brain in late-onset restless legs syndrome.

Family study of restless legs syndrome in Quebec, Canada: clinical characterization of 671 familial cases.

Restless legs syndrome: understanding its consequences and the need for better treatment.

Neuropathological examination suggests impaired brain iron acquisition in restless legs syndrome.

Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

P304

716-725

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2015.1058140

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P50

Richard P Allen

P577

2015-06-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26077324

http://www.w3.org/2001/XMLSchema#string

P921

dopamine

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.

about

P2860

P2860

Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921